miRNA Mechanism of Acute Kidney Injury in Aging

衰老过程中急性肾损伤的 miRNA 机制

基本信息

  • 批准号:
    9947747
  • 负责人:
  • 金额:
    $ 54.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-31 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary Ischemia/reperfusion (I/R)-induced acute kidney injury (AKI) remains a major clinical problem in older population. Although I/R-induced AKI occurs in a variety of clinical situations such as shock, renal transplantation, sepsis and renal artery stenosis, the mechanism is multifactorial, complex and poorly understood. Under normal physiological conditions, kidney produces hydrogen sulfide (H2S) with the aid of four enzymes: cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE), 3-mercaptopyruvate sulfurtransferase (3MST), and cysteine aminotransferase (CAT). In recent years, H2S has been shown to regulate several physiological functions, and its decrease has been implicated in diseases such as hypertension, inflammation, atherosclerosis, and renal disease progression and failure. MicroRNA’s (miRNAs) are small non-coding RNA’s, which has the ability to inhibit mRNA transcripts by inducing degradation or blocking protein translation. In I/R- induced AKI, several miRNAs have been reported to be differentially expressed. Furthermore, in I/R-induced AKI macrophages play a key role in inflammatory and reparative process. While M1 subset macrophage is involved in inflammation, subset M2 is involved in repair mechanism. Our preliminary results suggested that in I/R-induced AKI in aging miRNA-21 is upregulated and miRNA-194 is down regulated. The injured kidney also showed decreased expression of CBS and 3MST enzymes leading to diminished H2S production. The increased ratio of M1/M2 further suggested prolonged inflammatory phase. In addition, expression of matrix metalloproteinase-9 (MMP-9) and their regulatory molecules, EMMPRIN and Meprin-A were also upregulated in AKI. These changes in concert with endothelial to mesenchymal transition (EndoMT) led us to strongly believing a detrimental remodeling in I/R-induced old kidney. Interestingly, H2S treatment mitigated remodeling and improved renal function in I/R-induced AKI in old mice. We obtained similar results through miR-21 inhibitor treatments. Based on these preliminary findings, we hypothesize that H2S is a protective agent against I/R-induced damage in aging kidney. In further substantiating our concept, both male and female, old vs young wild type (WT, C57BL/6J) mice will be used to compare severity of I/R-induced kidney injury and dysfunction, and beneficial effects of H2S treatment will be assessed. The gained knowledge will not only help to better understand mechanisms of AKI in aging, but will also shed lights on future diagnostic and therapeutic strategies which will be applicable to older patients suffering from AKI.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Utpal Sen其他文献

Utpal Sen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Utpal Sen', 18)}}的其他基金

miRNA Mechanism of Acute Kidney Injury in Aging
衰老过程中急性肾损伤的 miRNA 机制
  • 批准号:
    9752532
  • 财政年份:
    2018
  • 资助金额:
    $ 54.53万
  • 项目类别:
Hydrogen sulfide mechanism of renal hypertension
硫化氢肾性高血压的机制
  • 批准号:
    9091516
  • 财政年份:
    2015
  • 资助金额:
    $ 54.53万
  • 项目类别:
Hydrogen sulfide mechanism of renal hypertension
硫化氢肾性高血压的机制
  • 批准号:
    8840391
  • 财政年份:
    2015
  • 资助金额:
    $ 54.53万
  • 项目类别:
Homocysteine and Angiotensin II in Renovascular Remodeling
同型半胱氨酸和血管紧张素 II 在肾血管重塑中的作用
  • 批准号:
    8108159
  • 财政年份:
    2011
  • 资助金额:
    $ 54.53万
  • 项目类别:
Homocysteine and Angiotensin II in Renovascular Remodeling
同型半胱氨酸和血管紧张素 II 在肾血管重塑中的作用
  • 批准号:
    8648856
  • 财政年份:
    2011
  • 资助金额:
    $ 54.53万
  • 项目类别:
Homocysteine and Angiotensin II in Renovascular Remodeling
同型半胱氨酸和血管紧张素 II 在肾血管重塑中的作用
  • 批准号:
    8259720
  • 财政年份:
    2011
  • 资助金额:
    $ 54.53万
  • 项目类别:
Homocysteine & Angiotensin II in Renovascular Remodeling
同型半胱氨酸
  • 批准号:
    8824551
  • 财政年份:
    2011
  • 资助金额:
    $ 54.53万
  • 项目类别:
Homocysteine and Angiotensin II in Renovascular Remodeling
同型半胱氨酸和血管紧张素 II 在肾血管重塑中的作用
  • 批准号:
    8441628
  • 财政年份:
    2011
  • 资助金额:
    $ 54.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了